Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos.
Popular Articles

Schwarzenegger's Call To Consider Marijuana Legalization To Boost Taxes Is "Irresponsible," Says Chairman Of DARE Board
Recent calls by California Gov. Arnold Schwarzenegger and others to study the legalization of marijuana as a way of boosting tax revenues are "irresponsible" and send a dangerous message, the chairman of the board of the drug abuse education program D.A.R.E., prominent Los Angeles attorney Louis "Skip" Miller, said today. "Marijuana is a dangerous drug with numerous demonstrable ill effects on health," Mr. Miller added.
pharmacy online
Cell Infected By Virus Viewed For The First Time By MSU Scientists
The June cover of the Journal of Virology features a photograph of the unusual effects on a cell infected by a virus. Montana State University researchers were the first to view the virus, which they collected from a boiling, acidic spring in Yellowstone.
News of the day
Many In Congress Hold Stakes In Health Industry
"Almost 30 key lawmakers helping draft landmark health-care legislation have financial holdings in the industry, totaling nearly $11 million worth of personal investments in a sector that could be dramatically reshaped by this summer"s debate," The Washington Post reports. The list of members includes "Congress"s most powerful leaders and a bipartisan collection of lawmakers in key committee posts." For example, Senate Majority Leader Harry Reid, D-Nev., "has at least $50,000 invested in a health-care index" (fund), and Sen. Judd Gregg, R-NH, "a senior member of the health committee, has between $254,000 and $560,000 worth of stock holdings in major health-care companies, including Bristol-Myers Squibb and Merck." The data was part of a "release of financial disclosure forms for the House and Senate" on Friday.
Endocrinology

Novartis To Partner With OneWorld Health To Develop Diarrhea Drug

"Swiss drug company Novartis AG and the Institute for OneWorld Health, a nonprofit group, will announce this week a partnership to discover drugs for a type of diarrhea that kills about 1.6 million children each year in the developing world," the Wall Street Journal reports. Though fluid treatments to prevent dehydration have helped "sharply cut the number of deaths" from secretory diarrhea in recent years "additional treatments are desperately needed, Richard Chin, chief executive of OneWorld Health, said in a phone interview," the newspaper writes. As part of the partnership, ten Novartis scientists will first sift through drugs candidates, before "pass[ing] along any promising candidates to OneWorld Health for further testing." The newspaper writes: "OneWorld Health, based in San Francisco, has been working on secretory diarrhea since 2006, using a $47 million grant from the Bill and Melinda Gates Foundation. The group already has a research partnership with Swiss drug company Roche Holding AG, which has allowed the nonprofit group to scan Roche"s library of experimental drugs for candidates that might work against diarrhea" (Whalen, 7/14). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009